Health
Virus drug benefit only marginal: study – Shepparton News
Moderately ill COVID-19 patients had their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir but the drug did not significantly shorten hospital stays and a 10-day course did not show a benefit, according to new data.The drug, which was shown in a trial of severely ill COVID-19 patients to shorten their hospital recovery time, has been at the forefront of the battle against the pandemic.The 600-patient analysis, published on Friday by the Journal of the American Medical …
-
General14 hours agoSpud King expands business with $14 million South West orchard investment
-
General13 hours agoFour bodies found in central Queensland house fire
-
Noosa News11 hours agoFour people killed as fire rips through home in Emerald, Queensland
-
General10 hours agoSydney man Danny Zayat found guilty of murdering Tatiana Dokhotaru in Liverpool apartment